Found: 8
Select item for more details and to access through your institution.
Intravasation as a Key Step in Cancer Metastasis.
- Published in:
- Biochemistry (00062979), 2019, v. 84, n. 7, p. 762, doi. 10.1134/S0006297919070071
- By:
- Publication type:
- Article
Intratumor heterogeneity: Nature and biological significance.
- Published in:
- Biochemistry (00062979), 2013, v. 78, n. 11, p. 1201, doi. 10.1134/S0006297913110011
- By:
- Publication type:
- Article
The Rarity of Metastasis to the Spleen — a Phenomenon with an Unknown Mechanism.
- Published in:
- Bulletin of Experimental Biology & Medicine, 2022, v. 173, n. 5, p. 575, doi. 10.1007/s10517-022-05591-3
- By:
- Publication type:
- Article
VALUABLE ASPECTS IN THE ENTERPRISE MANAGEMENT PROCESS.
- Published in:
- Financial & Credit Activity: Problems of Theory & Practice, 2020, v. 1, n. 32, p. 206, doi. 10.18371/fcaptp.v1i32.200371
- By:
- Publication type:
- Article
Molecular subtype conversion in CTCs as indicator of treatment adequacy associated with metastasis-free survival in breast cancer.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-25609-0
- By:
- Publication type:
- Article
Heterogeneity of premetastatic niche gene expression in breast cancer cells.
- Published in:
- Biopolymers & Cell, 2015, v. 31, n. 6, p. 429, doi. 10.7124/bc.000900
- By:
- Publication type:
- Article
EpCAM-CD24+ circulating cells associated with poor prognosis in breast cancer patients.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-61516-2
- By:
- Publication type:
- Article
Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Contributes to Tamoxifen Resistance in Estrogen-Positive Breast Cancer Patients.
- Published in:
- Molecular Biology, 2021, v. 55, n. 1, p. 102, doi. 10.1134/S0026893321010052
- By:
- Publication type:
- Article